RA Capital Management, LP ("RA Capital"), a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies, today ...
the loss of patent protection for big-selling multiple sclerosis therapy Copaxone (glatiramer acetate), and saddled with debt from its takeover of generics business Actavis. Since then ...
including the reverse merger with Actavis. On the profitability side, 10 out of the top 20 companies reported over 25% growth in net profit. Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb ...